Sales & Marketing
Biotech is back, with Craig Ackerman
In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
R&D
LSX2026: On a therapeutic vision for ocular disease, with Al...
Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Patients
LSX2026: On promise and patience, with Hans Schambye
At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Market Access
BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...
Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.
Patients
Using patient data to fill in GLP-1 blind spots, with Phil J...
At Reuters Pharma USA, Evidation Health's Phil Johnson talks about what pharma needs to know about their GLP-1 patients and how better data can help.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
